Clinical management factors contribute to the decision for contralateral prophylactic mastectomy

Journal of Clinical Oncology

Volumn 29, Issue 16, 2011, Pages 2158-2164

  King, Tari A ^a   Sakr, Rita ^a   Patil, Sujata ^a   Gurevich, Inga ^a   Stempel, Michelle ^a   Sampson, Michelle ^a   Morrow, Monica ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER STAGING; CANCER SURGERY; CLINICAL DECISION MAKING; CONTRALATERAL BREAST CANCER; CONTRALATERAL PROPHYLACTIC MASTECTOMY; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MASTECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SURGEON;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MASTECTOMY; MEDICAL ONCOLOGY; MIDDLE AGED; NEOPLASM STAGING; PHYSICIAN'S PRACTICE PATTERNS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 79957967253     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.29.4041     Document Type: Article

References (30)

1. Arrington AK, Jarosek SL, Virnig BA, et al: Patient and surgeon characteristics associated with increased use of contralateral prophylactic mastectomy in patients with breast cancer. Ann Surg Oncol 16:2697-2704, 2009
2. Jones NB, Wilson J, Kotur L, et al: Contralateral prophylactic mastectomy for unilateral breast cancer: An increasing trend at a single institution. Ann Surg Oncol 16:2691-2696, 2009
3. Tuttle TM, Habermann EB, Grund EH, et al: Increasing use of contralateral prophylactic mastectomy for breast cancer patients: A trend toward more aggressive surgical treatment. J Clin Oncol 25:5203-5209, 2007 (Pubitemid 350232251)
4. Tuttle TM, Jarosek S, Habermann EB, et al: Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ. J Clin Oncol 27:1362-1367, 2009
5. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
6. Forbes JF, Cuzick J, Buzdar A, et al: Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 100-month analysis of the ATAC trial. Lancet Oncol 9:45-53, 2008
7. Romond EH, Perez EA, Bryant J, et al: Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 353: 1673-1684, 2005 (Pubitemid 41464706)
8. Hislop TG, Elwood JM, Coldman AJ, et al: Second primary cancers of the breast: Incidence and risk factors. Br J Cancer 49:79-85, 1984 (Pubitemid 14194030)
9. Kollias J, Ellis IO, Elston CW, et al: Clinical and histological predictors of contralateral breast cancer. Eur J Surg Oncol 25:584-589, 1999
10. Rosen PP, Groshen S, Kinne DW, et al: Contralateral breast carcinoma: An assessment of risk and prognosis in stage I (T1N0M0) and stage II (T1N1M0) patients with 20-year follow-up. Surgery 106:904-910, 1989 (Pubitemid 19283388)
11. Saphner T, Tormey DC, Gray R: Annual hazard rates of recurrence for breast cancer after primary therapy. J Clin Oncol 14:2738-2746, 1996 (Pubitemid 26329660)
12. Gao X, Fisher SG, Emami B: Risk of second primary cancer in the contralateral breast in women treated for early-stage breast cancer: A population-based study. Int J Radiat Oncol Biol Phys 56:1038-1045, 2003 (Pubitemid 36794035)
13. Nathanson KL, Wooster R, Weber BL: Breast cancer genetics: What we know and what we need. Nat Med 7:552-556, 2001 (Pubitemid 32448321)
14. Yi M, Hunt KK, Arun BK, et al: Factors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomy. Cancer Prev Res (Phila) 3:1026-1034, 2010
15. Lostumbo L, Carbine N, Wallace J, et al: Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 4:CD002748, 2004
16. Bleicher RJ, Ciocca RM, Egleston BL, et al: Association of routine pretreatment magnetic resonance imaging with time to surgery, mastectomy rate, and margin status. J Am Coll Surg 209:180-187, 2009
17. Houssami N, Ciatto S, Macaskill P, et al: Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: Systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol 26:3248-3258, 2008
18. Katipamula R, Degnim AC, Hoskin T, et al: Trends in mastectomy rates at the Mayo Clinic Rochester: Effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 27:4082-4088, 2009
19. Sorbero ME, Dick AW, Beckjord EB, et al: Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol 16:1597-1605, 2009
20. Tuttle TM: Counseling breast cancer patients on contralateral prophylactic mastectomy: The physician's role. Oncology (Williston Park) 22:545-548, 2008
21. Dupont EL, Kuhn MA, McCann C, et al: The role of sentinel lymph node biopsy in women undergoing prophylactic mastectomy. Am J Surg 180:274-277, 2000
22. Yi M, Meric-Bernstam F, Middleton LP, et al: Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy. Cancer 115:962-971, 2009
23. Bedrosian I, Hu CY, Chang GJ: Population-based study of contralateral prophylactic mastectomy and survival outcomes of breast cancer patients. J Natl Cancer Inst 102:401-409, 2010
24. McLaughlin SA, Stempel M, Morris EA, et al: Can magnetic resonance imaging be used to select patients for sentinel lymph node biopsy in prophylactic mastectomy? Cancer 112:1214-1221, 2008
25. Berg WA, Gutierrez L, NessAiver MS, et al: Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 233:830-849, 2004
26. Lehman CD, Gatsonis C, Kuhl CK, et al: MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 356:1295-1303, 2007 (Pubitemid 46513295)
27. Morrow M, Jagsi R, Alderman AK, et al: Surgeon recommendations and receipt of mastectomy for treatment of breast cancer. JAMA 302:1551-1556, 2009
28. Singletary SE: Surgical margins in patients with early-stage breast cancer treated with breast conservation therapy. Am J Surg 184:383-393, 2002
29. Ess S, Savidan A, Frick H, et al: Geographic variation in breast cancer care in Switzerland. Cancer Epidemiol 34:116-121, 2010
30. McGuire KP, Santillan AA, Kaur P, et al: Are mastectomies on the rise? A 13-year trend analysis of the selection of mastectomy versus breast conservation therapy in 5865 patients. Ann Surg Oncol 16:2682-2690, 2009